Expertise
Viral vector development for gene delivery/gene therapy
Our Measles-derived Virosomes can be used as a Adeno/AAV viral vectors
Author
CEO
SAGITTA BIOTECH
Liège, Liège, Belgium
Ben is active in Tech SMEs for 22 years (as CEO, Head of BD, COO, etc). Ben has a PhD in Immunology, and a MBA from Solvay Business School.
Phd in Immunology and MBA from Solvay.
Managing Biotech companies since 2003.
My organisation
Skills
Interests
Expertise
Viral vector development for gene delivery/gene therapy
Our Measles-derived Virosomes can be used as a Adeno/AAV viral vectors